-

Hagens Berman: Expanded Class-Action Lawsuit Against the NCAA Seeks Broader Damages for College Athletes Denied Name, Image and Likeness Rights

Amended lawsuit adds admissions from the NCAA that athletes profiting from NILs is good, broadens damages sought

OAKLAND, Calif.--(BUSINESS WIRE)--Attorneys at Hagens Berman representing college athletes against the NCAA and Power Five Conferences in a class-action lawsuit regarding compensation rights for their names, images and likenesses (NILs) have filed an amended lawsuit broadening damages sought and adding new information since the NCAA temporarily suspended many of its NIL rules.

The amended complaint was filed July 26, 2021, and combines Hagens Berman’s House v. NCAA case and an additional case into one consolidated action titled In re College Athlete NIL Litigation. The filing also adds new admissions from the NCAA and other defendant representatives that allowing NIL is good – a drastic change from their past statements that allowing NIL would ruin college sports.

“We’re using the same playbook implemented by any successful team: re-strategize based on what you learn from studying your opponent, and coordinate your offense,” said Steve Berman, managing partner of Hagens Berman and attorney for the proposed class. “We think it’s important for the court to be aware that the NCAA has abruptly changed its public stance on NIL rights. NCAA athletes are already reaping the benefits, which only makes our case stronger.”

“We also wanted to make sure that any college athletes receiving the current NIL deal benefit while the NCAA has temporarily suspended many of its rules regarding NIL compensation, are also securely part of this suit,” Berman added. “The NCAA has changed its tactics after college athletes won in Alston, and only then was the NCAA forced to make concessions.”

In June 2021, the court upheld all of the claims brought in Hagens Berman’s case amid the NCAA’s motions to dismiss.

The antitrust lawsuit was filed June 15, 2020, in the U.S. District Court for the Northern District of California, and accuses the NCAA and conferences of illegally conspiring to limit the compensation that Division I college athletes may receive for the use of their NILs and athletic reputations. The complaint says the entities violated federal antitrust laws in abiding by a particular subset of NCAA rules that prohibit college athletes from receiving anything of value in exchange for the commercial use of their NIL.

“Only under the most intense public and legal pressure has the NCAA adopted a non-permanent, ‘interim’ policy change that has, at long last, permitted many forms of third party NIL compensation to student-athletes to take place,” the complaint states.

“The NCAA was hoping the Supreme Court would adopt its and the Conferences’ arguments that NCAA compensation restraints—including NIL restraints—should be immunized from ordinary rule of reason scrutiny whenever the restraints are ostensibly justified on the basis of amateurism,” according to the lawsuit. “While waiting for the Supreme Court’s decision in Alston, the NCAA simultaneously continued its efforts to lobby Congress for a ‘safe harbor’ from antitrust lawsuits challenging NCAA NIL rules (including this case). It also continued to keep on hold any changes in its NIL restraints, even though a number of state NIL laws were due to go into effect on July 1.”

Head-to-Head with the NCAA

In the amended filing, in addition to the expanded damages classes, the lawsuit highlights numerous examples of what types of NIL deals student-athletes have been doing since many of the NCAA’s NIL rules were temporarily suspended on July 1, 2021.

The suit states that “thousands of student-athletes have already taken advantage of the NIL opportunities available to them since July 1,” in partnerships with clothing brands, beverage companies, restaurants, cell phone companies, video game platforms, and other national and local retailers. Unilever, for example, plans to spend $5 million over the next five years in partnerships with college athletes promoting the deodorant brand Degree, and Alabama’s presumptive starting quarterback has already earned close to $1 million, according to the team’s coach.

The suit also draws attention to new admissions from the NCAA and other defendant representatives of the benefits of allowing compensation for athletes’ NILs. Despite these admissions, the lawsuit says that the NCAA has kept in place, even under its “interim” policy, some of the most restrictive aspects of its NIL rules.

The lawsuit seeks to hold the NCAA accountable to college athletes via injunction and damages for the NCAA’s antitrust violations regulating the profits gained from the use of college athletes’ names, images and likenesses, specifically:

  • An injunction voiding rules prohibiting compensation to college athletes for use of their name, image and likeness.
  • Damages based on payments college athletes would have received if not for the NCAA’s restraints. These revenues include social media earnings and revenues from group licenses.
  • A newly expanded class of damages: a class that will encompass all student-athletes who get any kind of NIL deal while many of the NCAA’s NIL rules have been temporarily suspended.

Find out more about the class-action lawsuit against the NCAA and its member conferences.

About Hagens Berman

Hagens Berman Sobol Shapiro LLP has represented classes of college students before, initiating and leading the historic Alston case where we won a 9-0 win for college athletes, achieving a $208 million settlement against the NCAA concerning antitrust-related student scholarship limits, a combined $60 million settlement against Electronic Arts and the NCAA regarding player likeness rights in videogames, and an additional settlement valued at $75 million regarding concussions and safety protocols and a trial victory overturning NCAA rules limiting education based compensation. The firm’s sports litigation legal team also includes former NCAA athletes.

Hagens Berman has 10 offices worldwide. The firm’s tenacious drive for plaintiffs’ rights has earned it numerous national accolades, awards and titles of “Most Feared Plaintiff’s Firm,” MVPs and Trailblazers of class-action law. More about the law firm and its successes can be found at www.hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contacts

Ashley Klann
pr@hbsslaw.com
206-268-9363

Hagens Berman Sobol Shapiro LLP


Release Summary
Attorneys at Hagens Berman representing college athletes against the NCAA in a lawsuit regarding compensation rights filed an amended, expanded case.
Release Versions

Contacts

Ashley Klann
pr@hbsslaw.com
206-268-9363

More News From Hagens Berman Sobol Shapiro LLP

Hagens Berman Investigating Rezolute, Inc. (RZLT) as Shares Tank 90% Amid Lead Asset Trial Failure

SAN FRANCISCO--(BUSINESS WIRE)--On December 11, 2025, investors in Rezolute, Inc. (NASDAQ: RZLT) saw the price of their shares crater as much as 90% during intraday trading after the company revealed the failure of its Phase 3 sunRIZE trial for ersodetug (“erso”). The company has billed this drug as a potential treatment for hypoglycemia caused by hyperinsulinism (“HI”). The news, analyst moves, and severe market reaction have prompted national shareholders rights firm Hagens Berman to open an...

KMX INVESTOR ALERT: CarMax (KMX) Securities Fraud Lawsuit Filed Over Alleged Concealed Demand Pull-Forward and Auto Finance Portfolio Risk – Hagens Berman

SAN FRANCISCO--(BUSINESS WIRE)--National investor rights law firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against CarMax, Inc. (NYSE: KMX) – January 2, 2026 – is rapidly approaching. The lawsuit alleges that CarMax and certain of its executives misled investors about the true stability and growth prospects of its core business, leading to two separate and massive stock crashes. Hagens Berman urges investors who suffered substantial...

MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

SAN FRANCISCO--(BUSINESS WIRE)--Global plaintiffs' rights firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) is rapidly approaching: December 15, 2025. The lawsuit alleges that MoonLake and certain executives made materially false and misleading statements regarding the clinical prospects of the company’s lead and sole drug candidate, sonelokimab (SLK), causing the stock to crash nearly...
Back to Newsroom